Navigation Links
Westaim announces sale of iFire Technology Ltd. assets
Date:10/17/2008

CALGARY, Oct. 17 /PRNewswire-FirstCall/ - The Westaim Corporation announced today a purchase and sale agreement between its wholly owned subsidiary iFire Technology Ltd. and CTS Group Limited. Under the agreement, iFire will sell its equipment, patents and intellectual property for net proceeds of approximately US$8.0 million. The sale is subject to several conditions, including iFire obtaining certain Government of Canada consents and approvals, which are expected to be obtained by mid-November. CTS Group is a Canadian-Chinese joint venture with established operations in Henan province, People's Republic of China.

"iFire management has worked very hard over the past few months to bring this transaction to completion," said Drew Fitch, President & CEO of Westaim. "The sale of iFire's assets will provide Westaim with additional cash resources as the company pursues its goal of strategically transitioning into a new sector."

Westaim previously announced it has entered into a reorganization agreement where it will acquire, subject to shareholder approval, several closely held and profitable businesses that provide products and services in the growing western Canadian construction industry. An information circular was mailed to shareholders on October 15th in advance of a special meeting of shareholders to be held on November 21, 2008. Westaim continues to hold a 74.5 percent interest in NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS).

The Westaim Corporation's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.

This news release contains forward-looking statements. These statements are based on current expectations that are subject to risks and uncertainties, and Westaim can give no assurance that these expectations are correct. Various factors could cause actual results to differ materially from those projected in such statements, including but not limited to statements regarding the sale of as
'/>"/>

SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Westaim announces 2008 second quarter results
2. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Second Quarter Results
3. Westaim announces 2008 first quarter results
4. Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
5. Westaim announces 2007 year-end results
6. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
7. Westaim reduces ABCP exposure
8. Westaim announces 2007 third quarter results
9. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
10. The Westaim Corporation update on status of short-term investments
11. US Oncologys Innovent Oncology Division Announces First Agreement Between Rocky Mountain Cancer Centers and Colorado Public Employees Retirement Association

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...HINGTON, Nov. 9 The Churchill Ce...ward For Leadership to J.W. "Bill" Marriott for hi...gh progressive free market practices and fostering...Mr. Marriott will receive his award at a ceremony ...on D.C. Four Seasons Hotel. ,, "This is a test...
(Date:11/9/2009)...lped men and women almost equally, study finds, ,...e widely used clot-dissolving drug Plavix (clopido...analysis of major clinical trials has found. , ...n treating both men and women with this very impor...f cardiovascular thrombosis at New York University...
(Date:11/9/2009)...n of plans finds differences in mood despite simil...hDay News) -- Both a high-fat, low-carbohydrate di...t, high-carb diet appear to help people lose pound...? Only the low-fat diets will result in long-term ...ov. 9 issue of Archives of Internal Medicine . ,...
(Date:11/9/2009)... Tomorrow may be too late when it ...ion, according to TOPS Club, Inc. (Take Off Pounds...nization. , (Vocus) Novem...mes to preventing or improving a diabetes conditio...ensibly), the nonprofit weight-loss support organi...
(Date:11/9/2009)...ANON, Tenn., Nov. 9 Health Connect...ced it will host their inaugural Hospital O.R. and...at the Marriott Renaissance Hotel in Nashville, Te...e than 100 hospital operating room directors and m...lth systems in the country. Some of the confirmed ...
Breaking Medicine News(10 mins):Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2
...tra El Cancer, an,organization dedicated to improv...ancer and their families, will host its Annual Hol...ients this Saturday, December 13, 2008. , Ch...ebrating holiday traditions. In addition to the s...
...Vital Images, Inc. (Nasdaq: VTAL ) , a leadin...on and analysis solutions, has named Ray A. Ghanba...d Products, a new position at ViTAL. Ghanbari repo...elopment and driving strategic business planning. ...
... this,afternoon by some major Michigan newspapers,...rmation about Executive Order (EO) budget cuts pro...y, the stories mistakenly reported:,"Another $5.3 ...ealth care treatment delivered to Medicaid patient...
...ER treatment, elective procedures, study says , ...re could be a shortage of 1,300 general surgeons i...at shortage could increase to 6,000 by 2050, a new...ency departments. A shortage of general surgeons m...
...consecutive year,hundreds of Conseco employees in ...eer for the needy of central Indiana as part of th...oliday season, Conseco partners with the United Ch...volunteers often add their,own donations and perfo...
...ernacional,S.A.B. de C.V. (BMV: LAB) ("Genomma Lab...unter ("OTC") pharmaceuticals and personal care pr...uidance. The Company expects to reach,organic gro...sed on the organic growth of core products (produc...
Other Medicine News:Health News:PADRES Contra El Cancer to Host its 10th Annual Posada Holiday Celebration for Children with Cancer 2Health News:Vital Images Names Healthcare Veteran Ray Ghanbari Executive Vice President of Strategy and Products 2Health News:Vital Images Names Healthcare Veteran Ray Ghanbari Executive Vice President of Strategy and Products 3Health News:U.S. May Soon Face Shortage of General Surgeons 2Health News:Conseco Employees Provide Holiday Cheer for 40 Central Indiana Families 2Health News:Genomma Lab Announces 2009 Earnings Guidance 2
(Date:11/9/2009)... Nov. 9 Cardiac Scienc...in automated external defibrillator ( AED ) and ...nced revenue of $38.9 million for the third quarte...ous guidance. The Company also recorded a charge o...d a non-cash charge of $44.0 million to increase i...
(Date:11/9/2009)...Nov. 9 Boston Scientific...edule of events at the 38th annual Global Congress...uns from November 15-19 in Orlando, Florida. Resu...aturing the Company,s Urology/Gynecology products,... mid-urethral sling systems used to treat pelvic f...
(Date:11/9/2009)...NCETON, N.J., Nov. 9 Pha...t will present at the Sixth Annual Lazard Capital ... be held at the St Regis Hotel in New York City (N...sset,s President and Chief Executive Officer, will...November 18, 2009 at 3:45 PM (ET). ,, To access...
Breaking Medicine Technology:Cardiac Science Announces Third Quarter Results 2Cardiac Science Announces Third Quarter Results 3Cardiac Science Announces Third Quarter Results 4Cardiac Science Announces Third Quarter Results 5Cardiac Science Announces Third Quarter Results 6Cardiac Science Announces Third Quarter Results 7Cardiac Science Announces Third Quarter Results 8Cardiac Science Announces Third Quarter Results 9Cardiac Science Announces Third Quarter Results 10Cardiac Science Announces Third Quarter Results 11Cardiac Science Announces Third Quarter Results 12Cardiac Science Announces Third Quarter Results 13Cardiac Science Announces Third Quarter Results 14Cardiac Science Announces Third Quarter Results 15Cardiac Science Announces Third Quarter Results 16Cardiac Science Announces Third Quarter Results 17Cardiac Science Announces Third Quarter Results 18Cardiac Science Announces Third Quarter Results 19Cardiac Science Announces Third Quarter Results 20Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 2Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 3Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 4Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 5Pharmasset to Present at Lazard Capital Markets Healthcare Conference 2Pharmasset to Present at Lazard Capital Markets Healthcare Conference 3CMPI to Host Hill Briefing Tomorrow on Follow on Biologic Drugs for Media and Congressional Staff With Reps Eshoo and Rogers 51694 1CMPI to Host Hill Briefing Tomorrow on Follow on Biologic Drugs for Media and Congressional Staff With Reps Eshoo and Rogers 51694 2Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 1Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 2Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 3Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 4Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 5Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 1Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 2Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 3
...Nektar Therapeutics,(Nasdaq: NKTR ) announced tod...for its pipeline programs will be presented at num...ing months. These presentations will,highlight Nek... oncology,anti-infectives and central nervous syst... molecule PEGylation and liquid aerosol platforms....
...w devices and research for,mechanical circulatory ...,of Health (NIH) National Heart, Lung, and Blood I...gram will be discussed at the International Societ...Annual Meeting and,Scientific Sessions. The meetin...ey Place and Hynes Convention Center., The use of...
Other Medicine Technology:Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings 2Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings 3Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings 4New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting 2
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: